Novus Holdings Ltd
JSE:NVS
Intrinsic Value
Novus Holdings Ltd. engages in the manufacture of tissue and printed products. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of NVS.
Fundamental Analysis
Balance Sheet Decomposition
Novus Holdings Ltd
| Current Assets | 2.3B |
| Cash & Short-Term Investments | 621.1m |
| Receivables | 923.5m |
| Other Current Assets | 801.3m |
| Non-Current Assets | 1.3B |
| Long-Term Investments | 82.7m |
| PP&E | 734.5m |
| Intangibles | 453.6m |
| Other Non-Current Assets | 72.6m |
| Current Liabilities | 862.7m |
| Accounts Payable | 763.9m |
| Other Current Liabilities | 98.8m |
| Non-Current Liabilities | 555.3m |
| Long-Term Debt | 375.9m |
| Other Non-Current Liabilities | 179.4m |
Earnings Waterfall
Novus Holdings Ltd
|
Revenue
|
5.2B
ZAR
|
|
Cost of Revenue
|
-4B
ZAR
|
|
Gross Profit
|
1.2B
ZAR
|
|
Operating Expenses
|
-916.8m
ZAR
|
|
Operating Income
|
264.9m
ZAR
|
|
Other Expenses
|
-102.9m
ZAR
|
|
Net Income
|
162m
ZAR
|
Free Cash Flow Analysis
Novus Holdings Ltd
NVS Profitability Score
Profitability Due Diligence
Novus Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Novus Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
NVS Solvency Score
Solvency Due Diligence
Novus Holdings Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Novus Holdings Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NVS Price Targets Summary
Novus Holdings Ltd
Shareholder Return
NVS Price
Novus Holdings Ltd
| Average Annual Return | 54.26% |
| Standard Deviation of Annual Returns | 134.99% |
| Max Drawdown | -85% |
| Market Capitalization | 1.5B Zac |
| Shares Outstanding | 3 188 697 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Novus Holdings Ltd. engages in the manufacture of tissue and printed products. The company is headquartered in Cape Town, Western Cape and currently employs 1,741 full-time employees. The company went IPO on 2015-03-31. The firm's principal operations are in print media, printing on packaging and the manufacture of tissue paper. Its segments include Printing and Other. The Printing segment is engaged in the printing of books, magazines, newspapers and related products. The Other segment includes the Labels division, which prints flexible labels, and Paarl Tissue Proprietary Limited, which manufactures tissue paper. The firm uses publication gravure, heatset Web offset, sheet-fed, specialized book, coldset Web offset, digital and ultraviolet (UV) flexographic technology in its printing processes. The firm offers printing services for various product categories, including magazines, retail inserts and catalogues, newspapers, security products, books and directories, labels and other flexible packaging products, and tissue products. Its activities are conducted primarily in South Africa.
You don't have any saved screeners yet
